Ujjain Medical Devices Park's 7 Key Facilities to Launch This Year
Ujjain Medical Devices Park Facilities Operational This Year

Ujjain Medical Devices Park's Seven Shared Facilities to Become Operational This Year

In a significant boost to India's medical device manufacturing sector, seven common infrastructure facilities at the Medical Devices Park in Ujjain are expected to be fully operational by the end of this year. This development marks a crucial transition from planning to execution phase for the park, which is being developed as a specialized hub for high-end medical equipment production.

Advanced Infrastructure to Support Local Manufacturing

The shared facilities will provide manufacturers of diagnostic kits for diseases including cancer, kidney ailments, and diabetes with access to sophisticated machinery and testing tools within the park premises. Additionally, producers of blood glucose monitoring systems, vacuum-assisted wound closure systems, and various other medical equipment will benefit from these centralized resources.

Machinery installation has already commenced for these shared facilities, signaling accelerated progress at the 360-acre industrial park. The initiative aims to substantially reduce manufacturers' dependence on external testing centers, lower compliance costs, and improve turnaround time for product validation and certification.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

Comprehensive Facility Details

The infrastructure being developed encompasses a complete ecosystem for medical device manufacturing:

  • 3D Printing and Prototyping Centre: For rapid product development and testing
  • Plastic Processing, Assembly and Packaging Unit: End-to-end production capabilities
  • Electrical Safety and Performance Testing Lab: Specifically for electromedical equipment
  • Tool Room for Mould and Die Manufacturing: Supporting precision component production
  • PCB Manufacturing Unit: For electronic medical devices
  • Biomedical and Biocompatibility Testing Lab: Ensuring medical safety standards
  • Micro and Sterility Testing Lab: Critical for infection control validation

These facilities are designed to support complete product development cycles within the park itself, creating a self-sufficient manufacturing ecosystem.

Industry Impact and Economic Benefits

Rajesh Rathod, Executive Director of Madhya Pradesh Industrial Development Corporation Ujjain, emphasized the transformative potential of these facilities. "Once functional, the facilities will significantly reduce testing and validation costs for industries as they will not have to depend on external labs," Rathod stated. "It will also shorten product development cycles and improve ease of doing business for manufacturers operating within the park."

The park has demonstrated strong early traction with all 360 acres fully allotted to 126 industries. Currently, approximately 18 units have begun construction activities, while four have already entered the production phase, indicating substantial ground-level progress.

This ambitious project involves proposed investments totaling Rs 3,265 crore and is projected to generate employment for over 12,800 people. The Medical Devices Park represents one of the key industrial clusters in Madhya Pradesh's emerging medical devices ecosystem, positioning the state as a significant player in this critical healthcare sector.

The development aligns with broader national initiatives to strengthen domestic medical device manufacturing capabilities and reduce import dependence in the healthcare sector. By providing comprehensive infrastructure support, the Ujjain park aims to attract both established manufacturers and innovative startups in the medical technology space.

Pickt after-article banner — collaborative shopping lists app with family illustration